JOURNEY MEDICAL CORPORATION - COMMON STOCK

5.1900

21-February-25 16:45:00

15 minutes delayed

Stocks

+0.0500

+0.97%

Today's range

5.0357 - 5.2150

ISIN

N/A

Source

NASDAQ

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

13 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

10 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
Journey Medical Corporation to Present at the Benzinga Global Small Cap Conference

07 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
Journey Medical Corporation Introduces Expanded Board of Directors

29 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
Journey Medical Corporation Announces Closing of Initial Public Offering

16 Nov 2021 16:01:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.